|
Senior Member
|
|
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
|
|
|
Senior Member
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
|
An excellent blog. Simon Stott, a researcher at Cambridge University, is doing a great job communicating the science of PD.
It's not a criticism of him, but what benefit will PwP get from any of this in 2018, or 2019, or 2020 ... ?
There's always going to be a lag between research and general use, so perhaps the question that I should be asking is:
What new therapies for PD will be introduced in 2018?
John
__________________
Born 1955. Diagnosed PD 2005.
Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg
Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg
|